The global market for EPA / DHA (Omega 3) Ingredients was estimated at US$3.1 Billion in 2024 and is projected to reach US$4.3 Billion by 2030, growing at a CAGR of 5.6% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the EPA / DHA (Omega 3) Ingredients market.
Food and beverage manufacturers are incorporating omega-3 ingredients into various products, including fortified dairy, infant formula, and plant-based alternatives. The pharmaceutical industry is also expanding its omega-3-based drug portfolio, particularly in cardiovascular treatments. The shift toward plant-based and sustainable omega-3 sources, such as algal oil, is gaining momentum, catering to vegan and vegetarian consumers. As dietary trends continue to emphasize functional and clean-label ingredients, the EPA/DHA omega-3 market is experiencing robust growth.
The pharmaceutical industry is also developing advanced formulations, such as high-concentration omega-3 ethyl esters and triglycerides, for prescription-based cardiovascular treatments. Regulatory approvals and clinical research supporting the health benefits of omega-3 fatty acids are further driving consumer confidence and market adoption. As innovations in sourcing, processing, and formulation continue, the EPA/DHA omega-3 market is poised for sustained growth and diversification across various applications.
The pharmaceutical industry`s growing reliance on omega-3 formulations for heart disease management, cognitive health, and inflammatory disorders is another key driver. The rise of personalized nutrition and targeted dietary supplementation is encouraging further innovation in omega-3 product offerings. With increasing investments in sustainability, technological improvements, and expanding consumer awareness, the EPA/DHA omega-3 market is expected to experience significant long-term growth.
Segments: Product (EPA, DHA); Source (Anchovy/Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil, Cod liver oil, Salmon oil, Krill oil, Menhaden oil); Application (Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
Global EPA/DHA (Omega-3) Ingredients Market - Key Trends & Drivers Summarized
Why Is the Demand for EPA/DHA Omega-3 Ingredients Rising?
The demand for EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) omega-3 ingredients is surging due to growing consumer awareness of their health benefits. These essential fatty acids play a critical role in cardiovascular health, cognitive function, eye health, and inflammation management. The increasing prevalence of heart disease, neurological disorders, and lifestyle-related conditions such as obesity and diabetes has prompted consumers to seek dietary supplements and functional foods enriched with omega-3s. The rise of preventive healthcare trends and personalized nutrition is further boosting the demand for EPA/DHA-based products.Food and beverage manufacturers are incorporating omega-3 ingredients into various products, including fortified dairy, infant formula, and plant-based alternatives. The pharmaceutical industry is also expanding its omega-3-based drug portfolio, particularly in cardiovascular treatments. The shift toward plant-based and sustainable omega-3 sources, such as algal oil, is gaining momentum, catering to vegan and vegetarian consumers. As dietary trends continue to emphasize functional and clean-label ingredients, the EPA/DHA omega-3 market is experiencing robust growth.
How Are Innovations in Sourcing and Processing Shaping the Market?
Technological advancements in omega-3 extraction and purification are enhancing product quality and sustainability. Traditional fish oil remains the primary source of EPA and DHA, but concerns over overfishing and marine ecosystem degradation have led to increased investments in alternative sources. Algal-based omega-3 production is emerging as a sustainable and environmentally friendly option, offering high purity and avoiding contaminants commonly found in marine fish. Additionally, microencapsulation technologies are improving the stability and bioavailability of omega-3s, allowing for their incorporation into a broader range of food and beverage products.The pharmaceutical industry is also developing advanced formulations, such as high-concentration omega-3 ethyl esters and triglycerides, for prescription-based cardiovascular treatments. Regulatory approvals and clinical research supporting the health benefits of omega-3 fatty acids are further driving consumer confidence and market adoption. As innovations in sourcing, processing, and formulation continue, the EPA/DHA omega-3 market is poised for sustained growth and diversification across various applications.
What Are the Key Factors Driving Growth in the EPA/DHA (Omega-3) Ingredients Market?
The growth in the EPA/DHA omega-3 ingredients market is driven by increasing consumer health consciousness, advancements in extraction and purification technologies, and expanding applications in pharmaceuticals, functional foods, and nutraceuticals. The demand for sustainable and plant-based omega-3 sources is rising as consumers prioritize ethical and environmentally friendly products. Additionally, the expansion of scientific research validating the health benefits of omega-3s is influencing regulatory approvals and product development.The pharmaceutical industry`s growing reliance on omega-3 formulations for heart disease management, cognitive health, and inflammatory disorders is another key driver. The rise of personalized nutrition and targeted dietary supplementation is encouraging further innovation in omega-3 product offerings. With increasing investments in sustainability, technological improvements, and expanding consumer awareness, the EPA/DHA omega-3 market is expected to experience significant long-term growth.
Report Scope
The report analyzes the EPA/DHA (Omega 3) Ingredients market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.Segments: Product (EPA, DHA); Source (Anchovy/Sardine Oils, High concentrates, Medium Concentrates, Low concentrates, Algae oil, Tuna oil, Cod liver oil, Salmon oil, Krill oil, Menhaden oil); Application (Dietary Supplements, Functional Food, Pharmaceutical Food, Infant Food, Others)
Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the EPA segment, which is expected to reach US$3.1 Billion by 2030 with a CAGR of a 6.4%. The DHA segment is also set to grow at 3.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $844.5 Million in 2024, and China, forecasted to grow at an impressive 9.0% CAGR to reach $873.3 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global EPA / DHA (Omega 3) Ingredients Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global EPA / DHA (Omega 3) Ingredients Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global EPA / DHA (Omega 3) Ingredients Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Aker BioMarine, Archer Daniels Midland (ADM), Arista Industries Inc, BASF SE, Cargill, Incorporated and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 44 Featured):
- Aker BioMarine
- Archer Daniels Midland (ADM)
- Arista Industries Inc
- BASF SE
- Cargill, Incorporated
- Cellana, Inc.
- Clover Corporation
- Copeinca ASA
- Corbion N.V.
- Croda International Plc
- DSM-Firmenich
- Epax Norway AS
- Golden Omega
- KD Pharma Group
- Kerry Group Plc
- Koninklijke DSM N.V.
- Nordic Naturals Inc
- Ocean Nutrition Canada
- Omega Protein
- Orkla ASA
Tariff Impact Analysis: Key Insights for 2025
Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.
What’s Included in This Edition:
- Tariff-adjusted market forecasts by region and segment
- Analysis of cost and supply chain implications by sourcing and trade exposure
- Strategic insights into geographic shifts
Buyers receive a free July 2025 update with:
- Finalized tariff impacts and new trade agreement effects
- Updated projections reflecting global sourcing and cost shifts
- Expanded country-specific coverage across the industry
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Aker BioMarine
- Archer Daniels Midland (ADM)
- Arista Industries Inc
- BASF SE
- Cargill, Incorporated
- Cellana, Inc.
- Clover Corporation
- Copeinca ASA
- Corbion N.V.
- Croda International Plc
- DSM-Firmenich
- Epax Norway AS
- Golden Omega
- KD Pharma Group
- Kerry Group Plc
- Koninklijke DSM N.V.
- Nordic Naturals Inc
- Ocean Nutrition Canada
- Omega Protein
- Orkla ASA
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 401 |
| Published | April 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 3.1 Billion |
| Forecasted Market Value ( USD | $ 4.3 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
